Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IVERIC bio, Inc.

IVERIC bio, Inc. (ISEE) Stock Overview

Explore IVERIC bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ISEE●NASDAQ
HealthcareBiotechnology
$39.95
$0.15(0.38%)
U.S. Market is Open · 15:10

IVERIC bio, Inc. (ISEE)

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-27.55
EPS (TTM)$-1.78
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$90.48

ISEE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IVERIC bio, Inc. (NASDAQ: ISEE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, IVERIC bio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ISEE on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $90.48 for the NASDAQ listing.

Key metrics behind IVERIC bio, Inc.'s NASDAQ-traded stock include a P/E ratio of -27.55 and a market capitalization of 5.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ISEE on the NASDAQ.

Price Performance (NASDAQ: ISEE)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.38%
3-Month Change
6.96%
6-Month Change
88.98%
Year-to-Date (YTD) Change
98.56%
1-Year Change
198.58%
3-Year Change
781.90%
5-Year Change
1504.42%
All-Time (Max) Change
51.90%

Contact Information

https://ivericbio.com
609 474 6755
8 Sylvan Way, Parsippany, NJ, 07054

Company Facts

1,630 Employees
IPO DateSep 25, 2013
CountryUS

Frequently Asked Questions